OmniAb (OABI) Deferred Taxes (2022 - 2026)
OmniAb's (OABI) quarterly Deferred Taxes came in at $442000.0 in Q1 2026, up 516.98% year-on-year from $71639.1 in Q1 2025, and up 216.01% on a QoQ basis from -$381000.0 in Q4 2025.
OmniAb (OABI) Deferred Taxes (2022 - 2026) Analysis & Trends
OmniAb (OABI) has 5 years of Deferred Taxes data on file, last reported at $442000.0 in Q1 2026.
- On a quarterly basis, Deferred Taxes rose 516.98% year-over-year to $442000.0 in Q1 2026; TTM through Mar 2026 was -$981000.0, a 84.97% increase from a year earlier, with the FY2025 full-year figure at -$1.5 million, up 83.09% from the prior year.
- Deferred Taxes for Q1 2026 stood at $442000.0, up from -$381000.0 in the prior quarter.
- Over the last five years, Deferred Taxes for OABI reached as high as $442000.0 in Q1 2026 and fell as low as -$5.1 million in Q4 2023.
- Historically, Deferred Taxes has averaged -$1.7 million across 5 years, with a median of -$1.9 million in 2024.
- Across the five-year window, Deferred Taxes sank 1304.99% in 2023 and surged 516.98% in 2026, its largest moves.
- Year by year, Deferred Taxes stood at $421000.0 in 2022, then sank by 1304.99% to -$5.1 million in 2023, then surged by 64.18% to -$1.8 million in 2024, then soared by 79.03% to -$381000.0 in 2025, then jumped by 216.01% to $442000.0 in 2026.
- Per Business Quant data, the three most recent Deferred Taxes figures were $442000.0 in Q1 2026, -$381000.0 in Q4 2025, and -$1.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -65.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 96.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | OmniAb | 261.62 Mn | 212.55 Mn | 14.41 Mn | 442,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 442,000.00 |
| Dec 31, 2025 | -381,000.00 |
| Sep 30, 2025 | -1.16 Mn |
| Jun 30, 2025 | 119,000.00 |
| Mar 31, 2025 | -106,000.00 |
| Dec 31, 2024 | -1.82 Mn |
| Sep 30, 2024 | -2.71 Mn |
| Jun 30, 2024 | -1.90 Mn |
| Mar 31, 2024 | -2.62 Mn |
| Dec 31, 2023 | -5.07 Mn |
| Sep 30, 2023 | -3.32 Mn |
| Jun 30, 2023 | -3.21 Mn |
| Mar 31, 2023 | -941,000.00 |
| Dec 31, 2022 | 421,000.00 |
| Sep 30, 2022 | -2.36 Mn |
| Jun 30, 2022 | -2.46 Mn |
| Mar 31, 2022 | -2.02 Mn |